Unbalanced risk-benefit analysis of ADHD drugs.

Lancet Psychiatry

London SE16 7RB, UK. Electronic address:

Published: November 2018

Download full-text PDF

Source
http://dx.doi.org/10.1016/S2215-0366(18)30349-3DOI Listing

Publication Analysis

Top Keywords

unbalanced risk-benefit
4
risk-benefit analysis
4
analysis adhd
4
adhd drugs
4
unbalanced
1
analysis
1
adhd
1
drugs
1

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!